A new drug for an old concept: aptamer to von Willebrand factor for prevention of arterial and microvascular thrombosis

por Veyradier, Agnès
Publicado 2020

Understanding pathophysiology of hemostasis disorders in critically ill patients with COVID-19

por Joly, Bérangère S., Siguret, Virginie, Veyradier, Agnès
Publicado 2020

The Specificities of Thrombotic Thrombocytopenic Purpura at Extreme Ages: A Narrative Review

por Joseph, Adrien, Joly, Bérangère S., Picod, Adrien, Veyradier, Agnès, Coppo, Paul
Publicado 2023

More on the use of frontline caplacizumab in immune-mediated thrombotic thrombocytopenic purpura

por Picod, Adrien, Benhamou, Ygal, Bouzid, Raïda, Veyradier, Agnès, Coppo, Paul
Publicado 2022

ADAMTS13 conformation is closed in non-immune acquired thrombotic thrombocytopenic purpura of unidentified pathophysiology

por Joly, Bérangère S., Roose, Elien, Coppo, Paul, Vanhoorelbeke, Karen, Veyradier, Agnès
Publicado 2022

Diagnosis and follow‐up of thrombotic thrombocytopenic purpura with an automated chemiluminescent ADAMTS13 activity immunoassay

por Beranger, Nicolas, Benghezal, Sandrine, Joly, Bérangère S., Capdenat, Sophie, Delton, Adeline, Stepanian, Alain, Coppo, Paul, Veyradier, Agnès
Publicado 2020

TTP: From empiricism for an enigmatic disease to targeted molecular therapies

por Graça, Nuno A. G., Joly, Bérangère S., Voorberg, Jan, Vanhoorelbeke, Karen, Béranger, Nicolas, Veyradier, Agnès, Coppo, Paul
Publicado 2022

Terminal Platelet Production is Regulated by Von Willebrand Factor

por Poirault-Chassac, Sonia, Nguyen, Kim Anh, Pietrzyk, Audrey, Casari, Caterina, Veyradier, Agnes, Denis, Cecile V., Baruch, Dominique
Publicado 2013

Dissecting the pathophysiology of immune thrombotic thrombocytopenic purpura: interplay between genes and environmental triggers

por Hrdinová, Johana, D’Angelo, Silvia, Graça, Nuno A. G., Ercig, Bogac, Vanhoorelbeke, Karen, Veyradier, Agnès, Voorberg, Jan, Coppo, Paul
Publicado 2018

Refractory Auto-Immune Thrombotic Thrombocytopenic Pupura Successfully Treated With Caplacizumab

por Mellaza, Chloé, Henry, Nicolas, Fayolle, Pierre-Marie, Mortaza, Satar, Subra, Jean-François, Veyradier, Agnès, Coppo, Paul, Augusto, Jean-François
Publicado 2020

Dissecting the pathophysiology of immune thrombotic thrombocytopenic purpura: interplay between genes and environmental triggers

por Hrdinová, Johana, D’Angelo, Silvia, Graça, Nuno A. G., Ercig, Bogac, Vanhoorelbeke, Karen, Veyradier, Agnès, Voorberg, Jan, Coppo, Paul
Publicado 2021

Incidence of obstetrical thrombotic thrombocytopenic purpura in a retrospective study within thrombocytopenic pregnant women. A difficult diagnosis and a treatable disease

por Delmas, Yahsou, Helou, Sébastien, Chabanier, Pierre, Ryman, Anne, Pelluard, Fanny, Carles, Dominique, Boisseau, Pierre, Veyradier, Agnès, Horovitz, Jacques, Coppo, Paul, Combe, Christian
Publicado 2015

Coagulation Disorders and Bleedings in Critically Ill Patients With Hemophagocytic Lymphohistiocytosis

por Valade, Sandrine, Azoulay, Elie, Galicier, Lionel, Boutboul, David, Zafrani, Lara, Stepanian, Alain, Canet, Emmanuel, Lemiale, Virginie, Venot, Marion, Veyradier, Agnès, Mariotte, Eric
Publicado 2015

HLA-DRB1*11 is a strong risk factor for acquired thrombotic thrombocytopenic purpura in children

por Joly, Bérangère S., Loiseau, Pascale, Darmon, Michael, Leblanc, Thierry, Chambost, Hervé, Fouyssac, Fanny, Guigonis, Vincent, Harambat, Jérôme, Stepanian, Alain, Coppo, Paul, Veyradier, Agnès
Publicado 2020

Predictive Scores for Early Identification of Immune-Mediated Thrombotic Thrombocytopenic Purpura: Room for Improvement?

por Joseph, Adrien, Brilland, Benoit, Burguet, Laure, Eloit, Martin, Fage, Nicolas, Augusto, Jean-François, Delmas, Yahsou, Veyradier, Agnès, Halimi, Jean-Michel, Coppo, Paul
Publicado 2022

The prognostic value of ADAMTS13 (a disintegrin and metalloprotease with thrombospondin type 1 repeats, member 13) deficiency in septic shock patients involves interleukin-6 and is...

por Peigne, Vincent, Azoulay, Elie, Coquet, Isaline, Mariotte, Eric, Darmon, Michael, Legendre, Paulette, Adoui, Nadir, Marfaing-Koka, Anne, Wolf, Martine, Schlemmer, Benoit, Veyradier, Agnès
Publicado 2013

ADAMTS13 and von Willebrand factor assessment in steady state and acute vaso‐occlusive crisis of sickle cell disease

por Demagny, Julien, Driss, Aurélie, Stepanian, Alain, Anguel, Nadia, Affo, Louis, Roux, Damien, Habibi, Anoosha, Benghezal, Sandrine, Capdenat, Sophie, Coppo, Paul, Driss, Françoise, Veyradier, Agnès
Publicado 2020

Measuring ADAMTS-13 activity to diagnose thrombotic thrombocytopenic purpura: a novel, fast fiber-optic surface plasmon resonance immunoassay

por Bonnez, Quintijn, Dekimpe, Charlotte, Tellier, Edwige, Kaplanski, Gilles, Verhamme, Peter, Tersteeg, Claudia, De Meyer, Simon F., Lammertyn, Jeroen, Joly, Bérangère, Coppo, Paul, Veyradier, Agnès, Vanhoorelbeke, Karen
Publicado 2023

Thrombotic Thrombocytopenic Purpura in Black People: Impact of Ethnicity on Survival and Genetic Risk Factors

por Martino, Suella, Jamme, Mathieu, Deligny, Christophe, Busson, Marc, Loiseau, Pascale, Azoulay, Elie, Galicier, Lionel, Pène, Frédéric, Provôt, François, Dossier, Antoine, Saheb, Samir, Veyradier, Agnès, Coppo, Paul
Publicado 2016

Modifying ADAMTS13 to modulate binding of pathogenic autoantibodies of patients with acquired thrombotic thrombocytopenic purpura

por Graça, Nuno A. G., Ercig, Bogac, Pereira, Leydi Carolina Velásquez, Kangro, Kadri, Kaijen, Paul, Nicolaes, Gerry A. F., Veyradier, Agnès, Coppo, Paul, Vanhoorelbeke, Karen, Männik, Andres, Voorberg, Jan
Publicado 2019